Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Secondary prevention after first stroke
ISRCTN ISRCTN35701810
ClinicalTrials.gov identifier
Public title Secondary prevention after first stroke
Scientific title Cluster randomised trial in a Primary Care database: utilising electronic patient records for intervention research into secondary prevention after first stroke
Acronym N/A
Serial number at source 086921
Study hypothesis We aim to provide ‘proof of concept’ of the feasibility and utility of implementing cluster randomised trials utilising electronic patient records in a large national primary care database.
Lay summary
Ethics approval London - Surrey Borders Research Ethics Committee approved on the 13th January 2010 (ref: 10/H0806/1)
Study design Interventional multicentre clustered randomised trial
Countries of recruitment United Kingdom
Disease/condition/study domain Stroke
Participants - inclusion criteria 1. All stroke patients (no age limit, either sex)
2. Registered at the practice for at least three years at the trial start date
3. First diagnosis of stroke recorded in the 24 month period before the trial start date
4. Medical code for stroke is entered during the consultation
5. Patient's electronic medical record includes previous stroke medical codes
Participants - exclusion criteria No eligible patients will be excluded from the analysis, to avoid bias.
Anticipated start date 01/04/2010
Anticipated end date 31/10/2011
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 50 GP practices per group (100 practices in total)
Interventions A series of electronic prompts will be activated at each consultation by patients with previous stroke, to promote adherence with evidence-based recommendations for secondary prevention of stroke and vascular disease following the National Guidelines (Intercollegiate Stroke Working Party [ICSWP], 2008). The prompts encourage primary care professional adherence with recommended processes of care. The prompts will also provide them with supporting information and links to evidence that supports the recommendations. The decision on whether to follow the treatment suggestions included in the prompt will be at the discretion of the GP. The GP will also be able to terminate display of the prompt at any time. Control practices will continue with usual care. The intervention will be implemented for 12 months at each practice.
Primary outcome measure(s) Difference in mean systolic blood pressure (BP) between intervention and control groups at 12 months adjusted for pre-intervention mean systolic BP
Secondary outcome measure(s) Measured at 12 months follow-up:
1. Mean diastolic blood pressure
2. Mean cholesterol concentration
3. Proportion of patients whose eligibility for anticoagulants/antiplatelet drugs is defined
4. Proportion of eligible patients that receive anticoagulant/antiplatelet drugs
5. Prescription adherence with prescribed medicines
6. Occurrence and hospitalisation with vascular events including transient ischaemic attack (TIA)/stroke, myocardial infarction, new-onset angina and mortality
Sources of funding The Wellcome Trust (UK) (grant ref: 086921)
Trial website
Publications
Contact name Prof  Martin  Gulliford
  Address Division of Primary Care and Public Health
King's College London
6th Floor Capital House
42 Weston Street
  City/town London
  Zip/Postcode SE1 3QD
  Country United Kingdom
  Email martin.gulliford@kcl.ac.uk
Sponsor The Wellcome Trust (UK)
  Address Gibbs Building
215 Euston Road
  City/town London
  Zip/Postcode NW1 2BE
  Country United Kingdom
  Email contact@wellcome.ac.uk
  Sponsor website: http://www.wellcome.ac.uk/
Date applied 16/03/2010
Last edited 17/03/2010
Date ISRCTN assigned 17/03/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central